Sort   by:  
 Page size 
TranscriptomicsMulticolor miRNA fluorescence in situ hybridization for tumor differential diagnosis
We profiled and quantitated miRNAs in two skin tumors (Basal cell carcinoma and Merkel cell carcinoma) and identified tumor-specific miRNAs. We used these tumor-specific miRNAs to guide development of miRNA fluorescence in situ hybridization. 2 barcoded sequencing runs, including 40 unique samples (...
ORGANISM(S): Homo sapiens 
2013-06-28 | E-GEOD-34137 | biostudies-arrayexpress
UnknownCharacterization of a Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cell Line CVG-1.
Not available
S-EPMC5905237 | biostudies-literature
UnknownThe biology and treatment of Merkel cell carcinoma: current understanding and research priorities.
Not available
S-EPMC6319370 | biostudies-literature
UnknownEfficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program.
Not available
S-EPMC7252959 | biostudies-literature
UnknownAvelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.
Not available
S-EPMC7885451 | biostudies-literature
UnknownNationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel.
Not available
S-EPMC9198700 | biostudies-literature
TranscriptomicsAnalysis of changes in gene expression in skin epidermis upon conditional knockout of PRC2-subunit Eed
Analysis of changes in gene expression in skin epidermis upon conditional knockout of the essential Polycomb repressive complex 2 (PRC2) subunit Eed. Loss of Eed in skin epithelium leads to de-repression of key Merkel-differentiation genes, which are known PRC2 targets, and results in ectopic format...
ORGANISM(S): Mus musculus 
2016-06-14 | E-GEOD-83244 | biostudies-arrayexpress
UnknownPembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study.
Not available
S-EPMC11511690 | biostudies-literature
UnknownDurable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.
Not available
S-EPMC6424137 | biostudies-literature
UnknownConcerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic.
Not available
S-EPMC8121899 | biostudies-literature
Sort   by:  
 Page size